Abstract
Morbidity and mortality from lung cancer is a major burden to global health. The integration of expert clinical experience, patient preference and high-quality evidence, including Cochrane systematic reviews, can only help improve outcomes from this highly lethal condition.
MeSH terms
-
Carcinoma, Non-Small-Cell Lung / therapy
-
Carcinoma, Small Cell / therapy
-
Evidence-Based Medicine
-
Humans
-
Lung Neoplasms / diagnosis
-
Lung Neoplasms / prevention & control
-
Lung Neoplasms / therapy*
-
Mass Screening / methods
-
Review Literature as Topic*
-
Smoking Cessation